ライフサイエンスコーパス: septal defect

1 Fallot or pulmonary atresia with ventricular septal defect.

2 th the pathogenesis of atrioventricular (AV) septal defect.

3 tricuspid atresia and large secundum atrial septal defect.

4 oplasia, hypertrabeculation, and ventricular septal defect.

5 uble-outlet right ventricle, and ventricular septal defect.

6 function, and had no evidence of ventricular septal defect.

7 ight ventricle with a concurrent ventricular septal defect.

8 birth with lung hypoplasia and a ventricular septal defect.

9 other cardiac defects including ventricular septal defect.

10 arge family with dominantly inherited atrial septal defect.

11 eptum and 298 (38%) for TGA with ventricular septal defect.

12 onding to surgical closure of a large atrial septal defect.

13 pproaches for simple lesions, such as atrial septal defect.

14 tium primum defect, a hallmark feature of AV septal defects.

15 humans, including dilated cardiomyopathy and septal defects.

16 iciency in mice could cause atrioventricular septal defects.

17 at different loci for atrial and ventricular septal defects.

18 7Bl/6 frequently have atrial and ventricular septal defects.

19 defects and C57Bl/6 to muscular ventricular septal defects.

20 uble outlet right ventricles and ventricular septal defects.

21 ction affect muscular ventricular and atrial septal defects.

22 ular septum and display profound ventricular septal defects.

23 e with thin ventricular wall and ventricular septal defects.

24 ed with the pathogenesis of atrioventricular septal defects.

25 , pulmonary artery stenosis, and ventricular septal defects.

26 rterial trunk and perimembranous ventricular septal defects.

27 s and between ozone and isolated ventricular septal defects.

28 ventricular (VSD) or atrioventricular (AVSD) septal defects.

29 ntribute to human congenital heart valve and septal defects.

30 esponsible for a subset of syndromic cardiac septal defects.

31 issense mutations that cause similar cardiac septal defects.

32 ionally inactive and segregated with cardiac septal defects.

33 or (CHF)1Hey2 gene show isolated ventricular septal defects.

34 for percutaneous closure of secundum atrial septal defects.

35 w tract alignment and membranous ventricular septal defects.

36 pecific defects, prevalence was greatest for septal defects.

37 n and between sertraline use and ventricular septal defects.

38 yndrome but inversely associated with atrial septal defects.

39 d efficacy of device closure of large atrial septal defects.

40 and perimembranous and muscular ventricular septal defects.

41 % CI, -0.74 to -0.09); and major ventricular septal defects, -0.25 (95% CI, -0.35 to -0.15).

42 interval, -0.87 to -0.10); major ventricular septal defects, -0.41 (95% confidence interval, -0.52 to

43 association was significant for ventricular septal defects (1.1% vs 0.6%; P = .001) and other CHDs (

44 premature CAD (OR for CoA versus ventricular septal defect, 1.44; 95% CI, 0.79-2.64) after adjustment

45 9 kindreds with familial CHD, 4 with atrial septal defects, 2 with patent ductus arteriosus, 2 with

46 iagnoses included tetralogy of Fallot (51%), septal defects (20%), (congenitally corrected) transposi

47 tricular septal defects (22/47, 47%), atrial septal defects (20/47, 43%), patent ductus arteriosus (1

48 rdiovascular anomalies, of which ventricular septal defects (22/47, 47%), atrial septal defects (20/4

49 400 patients, 154 (38.3%) with a ventricular septal defect, 238 (59.5%) with an intact septum, and 9

50 d with 224 of 6481 patients with ventricular septal defect (4.9% versus 3.5%; P=0.04).

51 ticularly high for isolated atrioventricular septal defects (4 of 5 [80%]) and laterality defects (7

52 the great arteries (8%), ventricular/atrial septal defects (8%), left ventricular outflow obstructio

53 Final QIs included: 8 for atrial septal defects; 9 for aortic coarctation; 12 for Eisenme

54 In the presence of an acute atrial septal defect, a Qp/Qs ratio of 1.3+/-0.2 was measured,

55 ural crest such as cleft palate, ventricular septal defect, abnormal development of hypoglossal nerve

56 ng aortic coarctation, ventricular or atrial septal defect, abnormal mitral valve, aortic root dilati

57 highest risk of IE in comparison with atrial septal defects (adjusted rate ratio, 95% confidence inte

58 ion, with d-TGA, with or without ventricular septal defects, admitted to our institution at 5 days of

59 right ventricle, and atrial and ventricular septal defects, all occurring with variable penetrance.

60 -) embryos revealed a membranous ventricular septal defect and an abnormal nodule of cartilage within

61 ulting from a profound subaortic ventricular septal defect and associated malalignment of the outflow

62 that confer greater susceptibility to atrial septal defect and atrioventricular septal defects and C5

63 cts, including liver hypotrophy, ventricular septal defect and haemorrhage.

64 icus, congestive heart failure due to atrial septal defect and hypernatremic dehydration due to diabe

65 ovascular development, including ventricular septal defect and non-compaction, as well as outflow tra

66 to-right shunting in the form of ventricular septal defect and paradoxical thromboembolism.

67 iduals with DS and complete atrioventricular septal defect and sequenced 2 candidate genes for CHD: C

68 igh penetrance, large membranous ventricular septal defects and a bifid cardiac apex, and less freque

69 ryonic death, but does result in ventricular septal defects and a low incidence of semilunar valve de

70 formations, including ventricular and atrial septal defects and a thin ventricular myocardium.

71 though human mutation of NKX2-5 is linked to septal defects and atrioventricular conduction abnormali

72 between carbon monoxide and isolated atrial septal defects and between ozone and isolated ventricula

73 may contribute to the development of atrial septal defects and bicuspid aortic valves.

74 nt in magnitude were detected between atrial septal defects and bromoform (aOR = 1.56; 95% CI: 1.01,

75 to atrial septal defect and atrioventricular septal defects and C57Bl/6 to muscular ventricular septa

76 Most cases of atrial septal defects and cardiomyopathy are not associated wit

77 ce, is a candidate causative gene for atrial septal defects and cardiomyopathy.

78 diogenic transcription factor, cause cardiac septal defects and cardiomyopathy.

79 xclusively to Lipid II binding, which causes septal defects and catastrophic cell envelope damage.

80 ts with CHD7 mutations, but atrioventricular septal defects and conotruncal heart defects are over-re

81 escribes the clinical aspects of ventricular septal defects and current management strategies.

82 , p.G115W, was identified in familial atrial septal defects and demonstrated decreased transactivatio

83 tion resulted in atrial and atrioventricular septal defects and hypoplasia of the developing DMP.

84 ct device for use in multifenestrated atrial septal defects and the fenestrated atrial septal defect

85 AC9 show a propensity for lethal ventricular septal defects and thin-walled myocardium.

86 cription factor gene, cause atrioventricular septal defects and valve abnormalities by disrupting a s

87 tidiastole of coronary heart disease, atrial septal defect, and atrial fibrillation are made, and the

88 of Fallot, overriding aorta with ventricular septal defect, and bicuspid aortic valves.

89 luding hypoplasia of myocardium, ventricular septal defect, and disorganized morphology.

90 poplastic myocardium, membranous ventricular septal defect, and double outlet right ventricle.

91 malities of the tricuspid valve, ventricular septal defect, and pulmonary stenosis, occur in the majo

92 yndrome of progressive RCM, atrioventricular septal defects, and a high prevalence of atrial fibrilla

93 d myocardium, ventricular and aortopulmonary septal defects, and abnormal smooth muscle development.

94 ble-outlet right ventricle, atrioventricular septal defects, and caval vein abnormalities.

95 elopment, bicuspid aortic valve, ventricular septal defects, and embryonic lethality.

96 such as cleft-lip and cleft-palate, cardiac septal defects, and eye defects.

97 embryos had a double outlet RV, ventricular septal defects, and hypertrophic myopathy, with near obl

98 ll, pulmonary-artery hypoplasia, ventricular septal defects, and hypoplastic left heart.

99 g double outlet right ventricle, ventricular-septal defects, and pericardial edema.

100 excluding ventricular septal defects, atrial septal defects, and pulmonary valve stenosis) occurred i

101 , double-outlet right ventricle, ventricular septal defects, and thin-walled myocardium.

102 c injuries such as coronary artery injuries, septal defects, and valvular injuries.

103 ogenesis, reduced ventricular trabeculation, septal defects, and valvular overgrowth.

104 aOR = 1.28; 95% CI: 1.03, 1.61), ventricular septal defect (aOR = 1.19; 95% CI: 1.00, 1.43), and tetr

105 al atresia/stenosis (aOR = 2.48), and atrial septal defect (aOR = 1.37).

106 sitively associated with the risks of atrial septal defect (aORs ranging from 1.29 to 2.17), patent d

107 ollutants and daily risks of secundum atrial septal defect, aortic coarctation, hypoplastic left hear

108 Most children with isolated atrial septal defects are free of symptoms, but the rates of ex

109 Conotruncal defects and atrioventricular septal defects are over-represented in patients with CHD

110 Ventricular septal defects are the most common congenital heart defe

111 Atrial septal defects are the third most common type of congeni

112 osure and closure of postinfarct ventricular septal defects, are also discussed.

113 s (aRR, 0.85; 95% CI, 0.75-0.96), and atrial septal defects (aRR, 0.82; 95% CI, 0.69-0.95) but not se

114 (aRR, 0.77; 95% CI, 0.61-0.96), ventricular septal defects (aRR, 0.85; 95% CI, 0.75-0.96), and atria

115 n a cohort of patients with atrioventricular septal defects as a part of Ellis van Creveld syndrome (

116 d male lethal condition encompassing cardiac septal defects, as well as ocular and dental anomalies.

117 eft-sided lesions (n = 160), secundum atrial septal defect (ASD) (n = 71), and Ebstein's malformation

118 Only one atrial septal defect (ASD) and two patent ductus arteriosus (PD

119 We compared administrative data for atrial septal defect (ASD) and ventricular septal defect (VSD)

120 ks is a complication of transcatheter atrial septal defect (ASD) closure.

121 (7)) with the risk of ostium secundum atrial septal defect (ASD) in the discovery cohort (N = 340 cas

122 n cause an autosomal dominant form of atrial septal defect (ASD), whereas others have identified muta

123 ccluder (HSO) with surgical repair of atrial septal defect (ASD).

124 solated procedures: device closure of atrial septal defect (ASD); device closure of patent ductus art

125 permanent synthetic implants to close atrial septal defects (ASD) and patent foramen ovale (PFO) has

126 anscatheter closures of secundum type atrial septal defects (ASD) and to assess ASD size and changes

127 e embryo and persistent ostium primum atrial septal defects (ASD) in approximately 20% of adults.

128 Transcatheter closure of secundum atrial septal defects (ASD) using the Amplatzer septal occluder

129 ive therapeutic option for congenital atrial septal defects (ASD).

130 E) in guiding percutaneous closure of atrial septal defects (ASD).

131 Atrial septal defects (ASDs) are a common human congenital hear

132 tions of closure devices for secundum atrial septal defects (ASDs) at a single institution.

133 dysregulation leads to development of atrial septal defects (ASDs) at high frequency.

134 Atrial septal defects (ASDs) can result from haploinsufficiency

135 de Lange syndrome-associated secundum atrial septal defects (ASDs) caused by NIPBL mutations, underta

136 d a high incidence of atrial and ventricular septal defects at birth.

137 transposition of great vessels, ventricular septal defect, atrial septal defect, tetralogy of Fallot

138 onchromosomal CHD (ie, excluding ventricular septal defects, atrial septal defects, and pulmonary val

139 f right dominant unbalanced atrioventricular septal defect (AVSD) remains challenging because unbalan

140 Atrioventricular septal defects (AVSD) are common cardiovascular malforma

141 Atrioventricular septal defects (AVSD) are the most commonly occurring he

142 enesis, resulting in severe atrioventricular septal defects (AVSD).

143 are associated with cardiac atrioventricular septal defects (AVSD).

144 Atrioventricular septal defects (AVSDs) are a common severe form of conge

145 Nonsyndromic atrioventricular septal defects (AVSDs) are an important subtype of CHDs

146 Atrioventricular septal defects (AVSDs) occur as a clinical feature of se

147 years) with large, isolated, secundum atrial septal defects (balloon-stretched diameter >/=34 mm in a

148 cardiography had abnormalities, with ventral septal defects being the most prevalent.

149 defect (SVASD) differs from secundum atrial septal defect by its atrial septal location and its asso

150 ranscatheter closure of muscular ventricular septal defects; (c) the transcatheter closure of perimem

151 A type of ventricular septal defect called the Gerbode defect, which results i

152 Postinfarction ventricular septal defect carries a grim prognosis.

153 ients (6%) in the pitavastatin group (atrial septal defect, chronic obstructive pulmonary disease, ch

154 ocedure (9%), patent foramen ovale or atrial septal defect closure (23%), cardiac metastasectomies or

155 with death after postinfarction ventricular septal defect closure included the following: age (hazar

156 Postinfarction ventricular septal defect closure was attempted in 53 patients from

157 Between 2008 and 2012, atrial septal defect closure with the AMPLATZER Septal Occluder

158 equent concomitant procedures such as atrial septal defect closure, arrhythmia surgery (the maze proc

159 scatheter valve replacements and ventricular septal defect closures have already been performed in ch

160 The associations with major ventricular septal defects, common arterial trunk, and anomalous pul

161 nital cardiac malformations like ventricular septal defects, common atrioventricular canal and double

162 ar septal defect, perimembranous ventricular septal defect, conotruncal defects, left ventricular out

163 analyses of probands with heterotaxy, atrial septal defects, conotruncal, and left ventricular outflo

164 r hypertrophy, overriding aorta, ventricular septal defects, coronary vessel abnormalities and valve

165 lities include overriding aorta, ventricular septal defects, cranial nerve, and craniofacial skeletal

166 theter closure of perimembranous ventricular septal defects; (d) the placement of bioprosthetic valve

167 y well-established techniques such as atrial septal defect device closure.

168 atzer Ductal Occluder, the cribriform atrial septal defect device for use in multifenestrated atrial

169 s using the Amplatzer membranous ventricular septal defect device have been encouraging.

170 livery system for the membranous ventricular septal defect device that is aimed to overcome the diffi

171 al septal defects and the fenestrated atrial septal defect device.

172 bserved an accuracy of 89.8% for ventricular septal defect diagnosis.

173 MII-B by 80% results in cardiac (ventricular septal defect, double outlet of the right ventricle) and

174 1-expressing progenitors display ventricular septal defects, double outlet right ventricle, semilunar

175 ardiac anomalies, including atrioventricular septal defects, Ebstein malformation of the tricuspid va

176 ive procedure to create or enlarge an atrial septal defect for the treatment of neonates with hypopla

177 Percutaneous treatment of inter-atrial septal defects has undergone exponential growth in the p

178 perative urgency and postinfarct ventricular septal defect, have been relatively stable over time, wh

179 s, congenital diaphragmatic hernias, cardiac septal defects, hearing loss and autistic and self-injur

180 omen had significantly higher ORs for atrial septal defects, hypoplastic left heart syndrome, aortic

181 1, which is associated with atrioventricular septal defect in people with or without DS, and HEY2, wh

182 openia, intermittent neutropenia, and atrial septal defects in 3 members of a consanguineous kindred.

183 Here, we show that isolated cardiac septal defects in a large pedigree were linked to chromo

184 ion of both miRNAs causes lethal ventricular-septal defects in approximately half of double-mutant em

185 with ventricular hypoplasia and ventricular septal defects in beta-myosin heavy chain-miR-195 transg

186 hysiology, treatment, and outcomes of atrial septal defects in children and adult patients in whom th

187 ch is demonstrated in characterizing cardiac septal defects in conditional mutant embryos lacking the

188 Because we observed ventricular septal defects in embryos that are null for the PDGFRbet

189 s responsible for heritable atrioventricular septal defects in six lines (avc1-6).

190 on, and partially penetrant atrioventricular septal defects, including ostium primum defects.

191 rged valve cusps, bicuspid aortic valve, and septal defects, indicating that endocardial Jag1 to Notc

192 aneous closure of postinfarction ventricular septal defect is a reasonably effective treatment for th

193 Atrioventricular septal defect is most often found associated with trisom

194 Atrial septal defect is one of the most common forms of congeni

195 mutation in TLL1 was identified in an atrial septal defects kindred and is predicted to affect the en

196 y increased by the presence of a ventricular septal defect, left ventricular outflow obstruction, sur

197 repaired "simple" lesions such as an atrial septal defect may not have normal survival if they are r

198 AV cushion defects including atrial septal defect, membranous VSD, and thickened valve leafl

199 s underwent repair of a secundum-type atrial septal defect (n=12) or patent foramen ovale (n=5) by a

200 o detected by micro-CT were atrioventricular septal defects (n=22), tricuspid hypoplasia/atresia (n=1

201 rn mice revealed an abundance of ventricular septal defects (n=307).

202 offspring with a perimembranous ventricular septal defect (odds ratio = 3.23, 95% confidence interva

203 and sulfur dioxide and isolated ventricular septal defects (odds ratio = 2.16, 95% confidence interv

204 in aerodynamic diameter and isolated atrial septal defects (odds ratio = 2.27, 95% confidence interv

205 95% CI, 1.6 to 20.7; 3 exposed subjects) and septal defects (odds ratio, 2.0; 95% CI, 1.2 to 4.0; 13

206 ance, such as cleft palate, choanal atresia, septal defects of the heart, haemorrhages, prenatal deat

207 We identified a new locus linked with atrial septal defect on chromosome 14q12 in a large family with

208 clamp times, and the presence of ventricular septal defects or abnormal coronary anatomy.

209 ocardial cushions accompanied by ventricular septal defects, outflow tract abnormalities and atrio-ve

210 eft superior vena cava (P=0.85), ventricular septal defect (P=0.12), and bicuspid aortic valve (P=0.1

211 ry homograft in 1, and overlying ventricular septal defect patch in 1.

212 annulus, (1B) ventriculotomy-to-ventricular septal defect patch, (2) ventriculotomy-to-pulmonary ann

213 nnulus, (3) pulmonary annulus-to-ventricular septal defect patch, and (4) ventricular septal defect p

214 lar septal defect patch, and (4) ventricular septal defect patch-to-tricuspid annulus.

215 t septum and an appropriate-size ventricular septal defect patch.

216 tflow tract (99%) or the site of ventricular septal defect patching (98%) and in the inferior RV inse

217 nes relevant for atrial and atrioventricular septal defects, patent ductus arteriosus, bicuspid aorti

218 the transcatheter closure of secundum atrial septal defects, patent foramen ovale, patent ductus arte

219 ventricular septum and TGA with ventricular septal defect performed from 2010 to 2013.

220 te GATA4 as a genetic cause of human cardiac septal defects, perhaps through its interaction with TBX

221 rt chambers, interatrial or interventricular septal defects, pericardium, and site and size of the gr

222 of the great arteries, muscular ventricular septal defect, perimembranous ventricular septal defect,

223 defects in the right ventricle, ventricular septal defect, persistent truncus arteriosus, reduced my

224 uding abnormalities of other cardiac valves, septal defects, persistent left superior vena cava, and

225 mily with forelimb anomalies and ventricular septal defects, phenotypes similar to Holt-Oram syndrome

226 erative repair of perimembranous ventricular septal defect (PMVSD) in a large multi-institutional dat

227 theter closure of perimembranous ventricular septal defects (PmVSDs) using the new Amplatzer Membrano

228 etween the use of sertraline and ventricular septal defects (relative risk, 1.04; 95% CI, 0.76 to 1.4

229 ents immediately prior to an elective atrial septal defect repair procedure.

230 that haploinsufficient versican mice display septal defects resembling those seen in Crtl1(-/-) embry

231 netically interact in vivo: atrioventricular septal defects result from endothelial-specific Gata4 an

232 Atrioventricular (AV) septal defects resulting from aberrant endocardial cushi

233 e TARP syndrome, talipes equinovarus, atrial septal defect, Robin sequence, and persistent left super

234 , but not a mutation causing secundum atrial septal defects (S52F), demonstrated impaired protein int

235 eta led to abnormal heart shape, ventricular septal defects, severe growth retardation, and postnatal

236 l period as well as for muscular ventricular septal defects should be the transcatheter approach.

237 Periostin null mice exhibit atrial septal defects, structural abnormalities of the AV valve

238 c NSML SHP2 expression developed ventricular septal defects, suggesting that NSML-associated mutation

239 or = 2 loci influence membranous ventricular septal defect susceptibility, whereas > or = loci and at

240 Sinus venosus atrial septal defect (SVASD) differs from secundum atrial septa

241 ith IAA associated with sinus venosus atrial septal defect (SVD) and partial anomalous pulmonary veno

242 included bifid atrial appendage, ventricular septal defect, tetralogy of Fallot (TOF), and an aortic

243 urgery for atrial septal defect, ventricular septal defect, tetralogy of Fallot, and transposition of

244 t vessels, ventricular septal defect, atrial septal defect, tetralogy of Fallot, coarctation of the a

245 with CHD (atrial septal defect, ventricular septal defect, tetralogy of Fallot, Ebstein anomaly, tra

246 tools, specifically in patients with atrial septal defects, tetralogy of Fallot, single ventricle ph

247 (TGA/IVS, n = 79, 63%), TGA with ventricular septal defect (TGA/VSD, n = 37, 30%), and Taussig Bing A

248 -long-term data for device closure of atrial septal defects, the incidence of late cardiac erosions,

249 ents with isolated atrial and/or ventricular septal defects, the predominant cardiac defects of the H

250 for Percutaneous Closure of Secundum Atrial Septal Defects; this study was approved by the Food and

251 the pilot in vivo study to create an atrial septal defect through the use of extracardiac applicatio

252 nts without prior diagnosis of PFO or atrial septal defect undergoing surgery at the Cleveland Clinic

253 and creation or enlargement of a ventricular septal defect using stents are potential therapeutic opt

254 Closure of large atrial septal defects using the Amplatzer device is safe and ef

255 device closure of perimembranous ventricular septal defects using the Amplatzer membranous ventricula

256 Sudden death after surgery for atrial septal defect, ventricular septal defect, tetralogy of F

257 2 cohorts: (1) all patients with CHD (atrial septal defect, ventricular septal defect, tetralogy of F

258 in the human proband, as well as ventricular septal defect (VSD) and double-outlet right ventricle (D

259 Prior ventricular septal defect (VSD) repair predicted neo-AI (p = 0.02) a

260 r atrial septal defect (ASD) and ventricular septal defect (VSD) surgeries in children 2 months to 19

261 rdiac morphogenesis, including a ventricular septal defect (VSD), abnormal formation of the aortic an

262 erved an increased risk of CHDs, ventricular septal defect (VSD), and tetralogy of fallot (TF) with i

263 g double-outlet right ventricle, ventricular septal defect (VSD), atrioventricular (AV) cushion defec

264 ith intact ventricular septum or ventricular septal defect (VSD), including double-outlet right ventr

265 ongenital heart disease, such as ventricular septal defect (VSD), myocardium noncompaction, and ventr

266 utlet right ventricle (DORV) and ventricular septal defect (VSD), similar to defects observed when ap

267 magnitude of shunting across the ventricular septal defect (VSD).

268 normalities, including PTA and a ventricular septal defect (VSD).

269 as identified with no associated ventricular septal defect (VSD).

270 omes after surgical closure of a ventricular septal defect (VSD).

271 utlet right ventricle (DORV) and ventricular septal defects (VSD).

272 Intramural ventricular septal defects (VSDs) are interventricular communication

273 ntal factors on the incidence of ventricular septal defects (VSDs) caused by a heterozygous Nkx2-5 kn

274 e closure of congenital muscular ventricular septal defects (VSDs) using the new Amplatzer mVSD occlu

275 Ventricular septal defects (VSDs) were associated with the highest b

276 kinking with 100% penetrance and ventricular septal defects (VSDs) with ~15% penetrance; Fz2(+/-);Fz7

277 fects within it, termed muscular ventricular septal defects (VSDs), are common, yet less is known abo

278 enital or postoperative residual ventricular septal defects (VSDs).

279 ith CoA compared with those with ventricular septal defect was determined.

280 In 9 of 10 canines, an atrial septal defect was produced, and shunting across the atri

281 Ventricular septal defect was the most common CHD observed, whereas

282 A large atrial septal defect was the only structural heart disease.

283 fic birth defects, only that for ventricular septal defects was significantly elevated, with an expos

284 Major ventricular septal defects were associated with larger HC relative t

285 Under real-time ultrasound guidance, atrial septal defects were successfully created with extracardi

286 , whereas outflow tract and atrioventricular septal defects were the most prevalent complex CHD.

287 d HEY2, whose mouse ortholog (Hey2) produces septal defects when mutated.

288 X5, another transcription factor that causes septal defects when mutated.

289 luding cardiac noncompaction and ventricular septal defect, which phenocopies 1p36 deletion syndrome

290 ased between 1990 and 2011 except for atrial septal defects, which increased significantly.

291 , ventricular noncompaction, and ventricular septal defects, while, in the postnatal cardiomyocyte, Q

292 tients with CoA and those with a ventricular septal defect, who are not known to be at increased risk

293 MRI demonstrated a ventricular septal defect with over-riding aorta.

294 sposition of the great arteries, ventricular septal defect with pulmonary stenosis (n=8).

295 Closure of atrial septal defect with the AMPLATZER Septal Occluder is safe

296 ethal and had complete atrioventricular (AV) septal defects with a single AV valve and myocardial thi

297 ac ventricular wall thinning and ventricular septal defects with double outlet right ventricle or ove

298 odel a specific subtype of atrio-ventricular septal defects with exclusive ventricular shunting and d

299 Pathology of the hearts showed atrial septal defects with minimal damage to surrounding tissue

300 erior cervical vertebral synostosis, cardiac septal defects with valve dysplasia, and deafness with i